David Zaccardelli is President and CEO of Verona Pharma plc. Currently has a direct ownership of 14.2 Million shares of VRNA, which is worth approximately $640 Million. The most recent transaction as insider was on Dec 06, 2024, when has been sold 162,800 shares (Ordinary Shares) at a price of $5.01 per share, resulting in proceeds of $815,628. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.2M
6.86% 3M change
13.51% 12M change
Total Value Held $640 Million

DAVID ZACCARDELLI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 06 2024
SELL
Open market or private sale
$815,628 $5.01 p/Share
162,800 Reduced 1.13%
14,204,752 Ordinary Shares
Dec 05 2024
SELL
Open market or private sale
$3,207,722 $5.01 p/Share
640,264 Reduced 4.27%
14,367,552 Ordinary Shares
Dec 04 2024
SELL
Open market or private sale
$338,040 $5.0 p/Share
67,608 Reduced 0.45%
15,007,816 Ordinary Shares
Dec 02 2024
SELL
Open market or private sale
$16,000 $5.0 p/Share
3,200 Reduced 0.02%
15,075,424 Ordinary Shares
Nov 29 2024
SELL
Open market or private sale
$495,428 $5.01 p/Share
98,888 Reduced 0.65%
15,078,624 Ordinary Shares
Nov 27 2024
SELL
Open market or private sale
$116,200 $5.0 p/Share
23,240 Reduced 0.15%
15,177,512 Ordinary Shares
Nov 25 2024
SELL
Open market or private sale
$8,000 $5.0 p/Share
1,600 Reduced 0.01%
15,200,752 Ordinary Shares
Nov 11 2024
SELL
Open market or private sale
$12,000 $5.0 p/Share
2,400 Reduced 0.02%
15,202,352 Ordinary Shares
Nov 04 2024
SELL
Open market or private sale
$413,292 $4.39 p/Share
94,144 Reduced 0.62%
15,204,752 Ordinary Shares
Nov 01 2024
SELL
Open market or private sale
$205,369 $4.38 p/Share
46,888 Reduced 0.31%
15,298,896 Ordinary Shares
Nov 01 2024
SELL
Payment of exercise price or tax liability
$1,042,836 $4.24 p/Share
245,952 Reduced 1.58%
15,345,784 Ordinary Shares
Nov 01 2024
BUY
Grant, award, or other acquisition
-
200,000 Added 1.27%
15,591,736 Ordinary Shares
Oct 30 2024
BUY
Grant, award, or other acquisition
-
800,000 Added 4.94%
15,391,736 Ordinary Shares
Oct 25 2024
SELL
Open market or private sale
$21,024 $4.38 p/Share
4,800 Reduced 0.03%
14,591,736 Ordinary Shares
Oct 24 2024
SELL
Open market or private sale
$613,200 $4.38 p/Share
140,000 Reduced 0.95%
14,596,536 Ordinary Shares
Oct 23 2024
SELL
Open market or private sale
$70 $4.38 p/Share
16 Reduced 0.0%
14,736,536 Ordinary Shares
Oct 22 2024
SELL
Open market or private sale
$693,233 $4.39 p/Share
157,912 Reduced 1.06%
14,736,552 Ordinary Shares
Oct 21 2024
SELL
Open market or private sale
$483,797 $4.38 p/Share
110,456 Reduced 0.74%
14,894,464 Ordinary Shares
Oct 18 2024
SELL
Open market or private sale
$1,076,533 $4.38 p/Share
245,784 Reduced 1.61%
15,004,920 Ordinary Shares
Sep 11 2024
SELL
Open market or private sale
$2,256,000 $3.76 p/Share
600,000 Reduced 3.79%
15,250,704 Ordinary Shares
Aug 13 2024
SELL
Open market or private sale
$1,286,832 $3.23 p/Share
398,400 Reduced 2.45%
15,850,704 Ordinary Shares
Aug 12 2024
SELL
Open market or private sale
$5,008 $3.13 p/Share
1,600 Reduced 0.01%
16,249,104 Ordinary Shares
Aug 07 2024
SELL
Payment of exercise price or tax liability
$824,776 $2.62 p/Share
314,800 Reduced 1.9%
16,250,704 Ordinary Shares
Aug 07 2024
BUY
Grant, award, or other acquisition
-
800,000 Added 4.61%
16,565,504 Ordinary Shares
Aug 01 2024
SELL
Payment of exercise price or tax liability
$250,579 $2.83 p/Share
88,544 Reduced 0.56%
15,765,504 Ordinary Shares
DZ

David Zaccardelli

President and CEO
London, X0

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA